- Home
- BDRX vs SPRC Comparison
BDRX vs SPRC Comparison
Compare BDRX & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDRX
- SPRC
- Stock Information
- Founded
- BDRX 2000
- SPRC 2004
- Country
- BDRX United Kingdom
- SPRC Israel
- Employees
- BDRX N/A
- SPRC N/A
- Industry
- BDRX Biotechnology: Pharmaceutical Preparations
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- BDRX Health Care
- SPRC Health Care
- Exchange
- BDRX Nasdaq
- SPRC Nasdaq
- Market Cap
- BDRX 3.6M
- SPRC 3.4M
- IPO Year
- BDRX N/A
- SPRC N/A
- Fundamental
- Price
- BDRX $1.15
- SPRC $0.31
- Analyst Decision
- BDRX
- SPRC
- Analyst Count
- BDRX 0
- SPRC 0
- Target Price
- BDRX N/A
- SPRC N/A
- AVG Volume (30 Days)
- BDRX 3.6M
- SPRC 302.0K
- Earning Date
- BDRX 04-11-2025
- SPRC 02-15-2025
- Dividend Yield
- BDRX N/A
- SPRC N/A
- EPS Growth
- BDRX N/A
- SPRC N/A
- EPS
- BDRX N/A
- SPRC N/A
- Revenue
- BDRX N/A
- SPRC $1,306,000.00
- Revenue This Year
- BDRX N/A
- SPRC N/A
- Revenue Next Year
- BDRX N/A
- SPRC N/A
- P/E Ratio
- BDRX N/A
- SPRC N/A
- Revenue Growth
- BDRX N/A
- SPRC N/A
- 52 Week Low
- BDRX $1.01
- SPRC $0.20
- 52 Week High
- BDRX $41.50
- SPRC $1.79
- Technical
- Relative Strength Index (RSI)
- BDRX 39.66
- SPRC 50.15
- Support Level
- BDRX $1.01
- SPRC $0.30
- Resistance Level
- BDRX $1.26
- SPRC $0.33
- Average True Range (ATR)
- BDRX 0.12
- SPRC 0.02
- MACD
- BDRX 0.01
- SPRC -0.00
- Stochastic Oscillator
- BDRX 15.22
- SPRC 58.82
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.